Medullary Thyroid Cancer: New Targeted Molecular Therapies
Journal:
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Volume:
4
Page:
10-14
Author(s):
Alessandro Antonelli, Silvia Martina Ferrari, Poupak Fallahi, Michele Minuto, Alda Corrado, Rossella Bruno and Paolo Miccoli
Patent Selections
Journal:
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Volume:
4
Page:
85-88
Author(s):
Bentham Science Publishers
Telomeres and Thyroid Cancer
Journal:
Current Genomics
Volume:
10
Page:
526-533
Author(s):
Marco Capezzone, Stefania Marchisotta, Silvia Cantara and Furio Pacini
An Emerging Strategy for Cancer Treatment Targeting Aberrant Glycogen Synthase Kinase 3β
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
9
Page:
1114-1122
Author(s):
Katsuyoshi Miyashita, Mitsutoshi Nakada, Abbas Shakoori, Yasuhito Ishigaki, Takeo Shimasaki, Yoshiharu Motoo, Kazuyuki Kawakami and Toshinari Minamoto
Increasing Sensitivity to Radiotherapy and Chemotherapy by Using Novel Biological Agents that Alter the Tumor Microenvironment
Journal:
Current Molecular Medicine
Volume:
9
Page:
1034-1045
Author(s):
E. T. Shinohara and A. Maity
Gadd45 Proteins as Critical Signal Transducers Linking NF-κB to MAPK Cascades
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
915-930
Author(s):
Z. Yang, L. Song and C. Huang
Clinical Development of MET Targeted Therapy For Human Cancer
Journal:
Current Cancer Therapy Reviews
Volume:
5
Page:
261-270
Author(s):
Nima Tirgan, Zhe Tang and Patrick C. Ma
Targeted Inhibition of AKT in Pancreatic Cancer
Journal:
Current Cancer Therapy Reviews
Volume:
5
Page:
288-295
Author(s):
Tawnya L. Bowles, Colin Parsons, Diego J. Muilenburg and Richard J. Bold
Thyroid Hormone Treatment for Differentiated Thyroid Carcinoma: What Drug, How Long, What Dose?
Journal:
Current Cancer Therapy Reviews
Volume:
5
Page:
296-302
Author(s):
Eliana Piantanida, Emanuele Compri, Myriam Gandolfo, Lorenza Sassi, Gianlorenzo Dionigi, Adriana Lai, Maria Laura Tanda and Luigi Bartalena
Recent Advances in Validating MDM2 as a Cancer Target
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
9
Page:
882-903
Author(s):
Elizabeth R. Rayburn, Scharri J. Ezell and Ruiwen Zhang